Welcome to LookChem.com Sign In|Join Free

CAS

  • or

125971-57-5

Post Buying Request

125971-57-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

125971-57-5 Usage

Chemical Properties

White Solid

Uses

Intermediate for the synthesis of pyrrole derivatives.

Check Digit Verification of cas no

The CAS Registry Mumber 125971-57-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,9,7 and 1 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 125971-57:
(8*1)+(7*2)+(6*5)+(5*9)+(4*7)+(3*1)+(2*5)+(1*7)=145
145 % 10 = 5
So 125971-57-5 is a valid CAS Registry Number.
InChI:InChI=1/C19H19NO2/c1-14(2)18(21)17(13-15-9-5-3-6-10-15)19(22)20-16-11-7-4-8-12-16/h3-14H,1-2H3,(H,20,22)/b17-13+

125971-57-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (2Z)-2-benzylidene-4-methyl-3-oxo-N-phenylpentanamide

1.2 Other means of identification

Product number -
Other names 2-Benzylidene isobutyryl acetanilide

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:125971-57-5 SDS

125971-57-5Relevant articles and documents

The convergent synthesis of CI-981, an optically active, highly potent, tissue selective inhibitor of HMG-CoA reductase

Baumann,Butler,Deering,Mennen,Millar,Nanninga,Palmer,Roth

, p. 2283 - 2284 (1992)

The synthesis of CI-981 is described starting from isobutyrylacetanilide (3) and the key chiral intermediate 2.

Preparation method of atorvastatin calcium isomers

-

Paragraph 0022; 0034; 0053-0054, (2018/09/11)

The invention relates to a preparation method of atorvastatin calcium isomers [R-(R*,R*)]-2-(3-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-2-phenyl-4-[(aniline)carbonyl]-1H-pyrrole-1-calciumenanthate salt (IMP-1 for short) and [R-(R*,R*)]-3-(2-fluorophenyl)-beta, delta-dihydroxyl -5-(1-Methylethyl)-3-phenyl-4-[(anilino)carbonyl]-1H-pyrrole-1- calcium enanthate salt (IMP-2 for short). According to the preparation method, a preparation method of a reference substance is provided for the quality research of drugs, and an important guiding significance is provided for the safe medicationof atorvastatin calcium.

The total synthesis of calcium atorvastatin

Dias, Luiz C.,Vieira, Adriano S.,Barreiro, Eliezer J.

supporting information, p. 2291 - 2296 (2016/03/01)

A practical and convergent asymmetric route to calcium atorvastatin (1) is reported. The synthesis of calcium atorvastatin (1) was performed using the remote 1,5-anti asymmetric induction in the boron-mediated aldol reaction of β-alkoxy methylketone (4) with pyrrolic aldehyde (3) as a key step. Calcium atorvastatin was obtained from aldehyde (3) after 6 steps, with a 41% overall yield.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 125971-57-5